Recalcitrant Reactive Perforating Collagenosis Successfully Treated with Dupilumab: A Case Report
DOI: https://doi.org/10.2147/ccid.s465766
2024-06-08
Clinical Cosmetic and Investigational Dermatology
Abstract:Jiecheng Li, Cheng Zhou Department of Dermatology, Peking University People's Hospital, Beijing, People's Republic of China Correspondence: Cheng Zhou, Department of Dermatology, Peking University People's hospital, Beijing, People's Republic of China, Email Reactive perforating collagenosis (RPC) is the most common form of the perforating dermatoses, which include RPC, elastosis perforans serpiginosa (EPS), perforating folliculitis (PF), and Kyrle disease (KD). In RPC, altered collagen of the dermis is extruded through the epidermis, which can be misdiagnosed as other skin diseases, such as vasculitis or prurigo nodularis. RPC is associated with a number of conditions, including diabetes mellitus, hepatitis, and renal failure, and thus the management of the coexisting diseases is important. There is currently no standardized and effective treatment method for RPC. Here, we report a patient with RPC who was resistant to topical corticosteroids, oral loratadine, and thalidomide, and responded well to dupilumab without significant side effects. Keywords: reactive perforating collagenosis, dupilumab, perforating dermatosis, biologic drug Reactive perforating collagenosis (RPC) is the most common form of the perforating dermatoses, which include RPC, elastosis perforans serpiginosa (EPS), perforating folliculitis (PF), and Kyrle disease (KD). 1 In RPC, altered collagen of the dermis is extruded through the epidermis, which can be misdiagnosed as other skin diseases, such as vasculitis. RPC is associated with a number of conditions, including diabetes mellitus, hepatitis, and renal failure, and thus the management of the coexisting diseases is important. 2 The lesion erupts but there are no clear guidelines for treatment. Here, we report a patient with RPC who was resistant to topical corticosteroids, oral loratadine, and thalidomide, and responded well to dupilumab without significant side effects. ggA 39-year-old female presented to our department with multiple well-defined keratotic papules and nodules with excoriations and crusts, on the trunk and limbs, which had appeared 6 months earlier without any specific trigger. Before presentation, she had been diagnosed with vasculitis at a local hospital and treated with topical corticosteroids, oral loratadine, and thalidomide, but with no response. Physical examination revealed brown keratotic papules with an erythematous border, crateriform appearance, and a central necrotic crust (Figure 1A–C). Laboratory tests revealed mildly elevated transaminase, which was related to her past history of hepatitis B infection, while a complete blood count, renal function, and thyroid function were normal. Antinuclear antibody and extractable nuclear antigen (ENA) panels were all negative. Skin biopsy and dermatopathological examination showed prominent epidermal hyperplasia with broad channels and invagination, with vertical extrusion of degenerated basophilic collagen bundles (Figure 2G). Masson's trichrome stain verified the transepidermal elimination of blue-stained collagen fibers (Figure 2H). The clinical and histopathological manifestations suggested the diagnosis of RPC. Considering that she was resistant to routine treatment and the risk of hepatitis B infection, she was treated with dupilumab, at an initial dosage of 600 mg and then 300 mg fortnightly. Three days after treatment, the pruritus improved significantly, with the numeric rating scale score dramatically decreasing from 9 to 1. After 12 weeks of treatment, the skin lesions had subsided, with no adverse effects reported (Figure 1D–F). Figure 1 ( A – C ) At the initial visit, excessive keratinization, umbilical papules, well-defined keratotic papules, nodules, and small vesiculation were observed on the trunk and limbs. ( D – F ) After nearly 12 weeks of subcutaneous dupilumab treatment, the lesions were flattened and showed post-inflammatory hyperpigmentation. Figure 2 ( A ) Biopsy examination (H&E stain) revealed a well-circumscribed area of necrosis filled with a keratotic plug and penetrating collagen fibers. There was a perivascular infiltration of lymphocytes and eosinophils in the superficial dermis. ( B ) Masson's trichrome stain showed transepidermal elimination of blue-stained collagen fibers. RPC was first reported by Mehregan et al in 1967. 3 There are two types of RPC, the hereditary form and the acquired form, which often coexist with diabetes, chronic renal failure, and other systemic diseases. The patient often presents with multiple diffusely distributed well-defined keratotic papules, which are most likely to occur on the trunk, limbs, and face, after scratching or irritating the skin. 4 The skin lesion biopsy exhibit -Abstract Truncated-
dermatology